Development and validation of an accurate quantitative real-time polymerase chain reaction-based assay for human blastocyst comprehensive chromosomal aneuploidy screening.
about
Pre-implantation genetic testing in ART: who will benefit and what is the evidence?Preimplantation genetic diagnosis of hemophilia AThe ageing ovary and uterus: new biological insightsLevels of trophectoderm mitochondrial DNA do not predict the reproductive potential of sibling embryos.The accumulation of vitrified oocytes is a strategy to increase the number of euploid available blastocysts for transfer after preimplantation genetic testing.Relationship Between Morphology, Euploidy and Implantation Potential of Cleavage and Blastocyst Stage EmbryosA greater number of euploid blastocysts in a given cohort predicts excellent outcomes in single embryo transfer cycles.Current status of comprehensive chromosome screening for elective single-embryo transfer.Selection of competent blastocysts for transfer by combining time-lapse monitoring and array CGH testing for patients undergoing preimplantation genetic screening: a prospective study with sibling oocytesClinical utilisation of a rapid low-pass whole genome sequencing technique for the diagnosis of aneuploidy in human embryos prior to implantationImproved sensitivity to detect recombination using qPCR for Dyskeratosis Congenita PGD.Aneuploidy across individual chromosomes at the embryonic level in trophectoderm biopsies: changes with patient age and chromosome structureApplication of next-generation sequencing technology for comprehensive aneuploidy screening of blastocysts in clinical preimplantation genetic screening cycles.Preimplantation Genetic Diagnosis: Prenatal Testing for Embryos Finally Achieving Its PotentialRandomized comparison of next-generation sequencing and array comparative genomic hybridization for preimplantation genetic screening: a pilot studyComparison of array comparative genomic hybridization and quantitative real-time PCR-based aneuploidy screening of blastocyst biopsiesApplication of next-generation sequencing for 24-chromosome aneuploidy screening of human preimplantation embryosCan Comprehensive Chromosome Screening Technology Improve IVF/ICSI Outcomes? A Meta-AnalysisAneuploidy rates and blastocyst formation after biopsy of morulae and early blastocysts on day 5.Single embryo transfer with comprehensive chromosome screening results in improved ongoing pregnancy rates and decreased miscarriage rates.Preimplantation genetic screening of blastocysts by multiplex qPCR followed by fresh embryo transfer: validation and verificationReduction of multiple pregnancies in the advanced maternal age population after implementation of an elective single embryo transfer policy coupled with enhanced embryo selection: pre- and post-intervention studyPreimplantation genetic screening for all 24 chromosomes by microarray comparative genomic hybridization significantly increases implantation rates and clinical pregnancy rates in patients undergoing in vitro fertilization with poor prognosis.45,X product of conception after preimplantation genetic diagnosis and euploid embryo transfer: evidence of a spontaneous conception confirmed by DNA fingerprintingIs the presence of an uncleaved embryo on day 3 a useful predictor of outcomes following day 5 transfer?Consistent and reproducible outcomes of blastocyst biopsy and aneuploidy screening across different biopsy practitioners: a multicentre study involving 2586 embryo biopsiesA review of, and commentary on, the ongoing second clinical introduction of preimplantation genetic screening (PGS) to routine IVF practiceLive births after simultaneous avoidance of monogenic diseases and chromosome abnormality by next-generation sequencing with linkage analysesA pilot proof-of-principle study to compare fresh and vitrified cycle preimplantation genetic screening by chromosome microarray and next generation sequencing.Incidental identification of balanced translocation carrier patients through comprehensive chromosome screening of IVF-derived blastocysts.Noninvasive chromosome screening of human embryos by genome sequencing of embryo culture medium for in vitro fertilization.A randomized and blinded comparison of qPCR and NGS-based detection of aneuploidy in a cell line mixture model of blastocyst biopsy mosaicismBest practices of ASRM and ESHRE: a journey through reproductive medicine.Polar bodies in assisted reproductive technology: current progress and future perspectives.Diagnosis of human preimplantation embryo viability.Pre-implantation genetic diagnosis and screening: now and the future.Mosaicism in Preimplantation Human Embryos: When Chromosomal Abnormalities Are the Norm.Evaluation of comprehensive chromosome screening platforms for the detection of mosaic segmental aneuploidyImplementing PGD/PGD-A in IVF clinics: considerations for the best laboratory approach and management.Preimplantation genetic screening 2.0: the theory
P2860
Q28072316-92FA4492-6EA3-4552-B615-4F3B5C61814FQ28073234-D894EC9A-35A0-40E2-9FC7-8B4FBC3664DDQ28278102-078D256E-948D-4136-80C2-965CAA2A1891Q33589708-3A51DEDB-77CF-4CB7-9E58-DF92B6DD6752Q33592827-F0FE804E-D336-4FFE-B11D-92156628B15CQ33604977-9DD93639-D75A-42A3-A632-B766CD220C1AQ33722006-80A1B1D7-BB42-4E44-8A91-6B1539C95020Q33759816-9A9D87C3-CAA8-421F-80CD-E35E196D25F9Q33830129-5BA23BE0-6E96-4563-B81E-1110590C3386Q33956545-ECEF46BE-61DF-44B8-918B-E9FD07DACDA5Q34145752-5BED46E6-5909-4903-9F4A-5190F2B20695Q35321057-B141BD89-7E1A-4D79-9A6D-9B74598075ACQ35357388-8A3FB164-C56D-4199-8C31-7BE917C3654DQ35667220-C1FF2658-3CC3-4307-AF99-D1210DDFB2D6Q35671340-7BA4FD45-EC26-4471-9163-304826E81041Q35722205-2BBDB03F-36C1-40FA-88E3-568F7F167182Q35748155-1242A04F-8578-4663-8C1C-A7C928906C01Q35808903-234559DA-AD71-4F30-AC8A-61C2A777FF15Q35816156-669DC317-4982-47CD-AFAC-5DF11E2C2BF2Q35829512-B15EC471-8C3D-4E85-88BF-BDA18B00E1EAQ35830644-ED58C384-C981-4FFB-99EF-045217319219Q35974858-D75E4B78-8381-4DA9-85C5-1BD33EB79C81Q36068679-92D81095-771A-4E4F-97F9-DE13A83D71A5Q36124689-B5EE6136-F257-4BEC-AD5D-142A3D48C05CQ36127755-DD3CB821-C504-4204-A42A-5CD6762E42DBQ36368721-7EF2E6B4-A601-4498-87B9-69E01F326B57Q36434649-0E90D3CC-18D1-428F-9544-D038DC5C4A8DQ36435251-16AB2A09-6265-4860-87ED-0A7F9A518892Q36714288-544FC9EF-D8A6-4533-A22B-6E3D59888BE6Q36966461-5DF46891-69BD-473A-9C6E-09E0EAF6E5E0Q37369285-D33615D8-DA9A-444A-8181-BE3C1EDCC1E4Q37444800-3152C368-18C6-4511-92B9-24A9840806A8Q38055459-F374D670-EA33-4174-9018-109F9CEB3960Q38282802-1BB393E9-CCB6-4380-9567-BAE8A174C408Q38310795-66EB8CD7-550F-468B-B21A-FB54DED1CD34Q38570199-6B5A0DE9-8A49-4C11-AC2F-2B734F302ED4Q38689280-8DA23B2A-FD70-4C49-80C2-A27A3B5D125DQ38701421-649007CA-38B7-49D4-AA87-948935BB8CD4Q38841178-37B7430C-7B7C-4D78-88D4-843B9030BD70Q38852209-6FE6FEB1-6EC9-4A28-8B28-67A306EB993E
P2860
Development and validation of an accurate quantitative real-time polymerase chain reaction-based assay for human blastocyst comprehensive chromosomal aneuploidy screening.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Development and validation of ...... omosomal aneuploidy screening.
@en
Development and validation of ...... omosomal aneuploidy screening.
@nl
type
label
Development and validation of ...... omosomal aneuploidy screening.
@en
Development and validation of ...... omosomal aneuploidy screening.
@nl
prefLabel
Development and validation of ...... omosomal aneuploidy screening.
@en
Development and validation of ...... omosomal aneuploidy screening.
@nl
P2093
P1476
Development and validation of ...... omosomal aneuploidy screening.
@en
P2093
Kathleen M Ferry
Nathan R Treff
Richard T Scott
P304
P356
10.1016/J.FERTNSTERT.2012.01.115
P407
P577
2012-02-18T00:00:00Z